Novartis | Räntekostnad På Skuld



Interest Expense On Debt Ändra Datum
AbbVie USD 610M 19M 2024-12
Alcon AG USD 48M 1000K 2024-12
Amgen USD 747M 29M 2024-12
AstraZeneca 429M 28M 2024-12
Bayer 703M 61M 2024-12
Biogen USD 60M 200K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Eli Lilly USD 224.7M 78.4M 2024-12
Fresenius 116M 105.2M 2024-09
Fresenius Medical Care EUR 101M 2M 2024-12
Galapagos EUR 50.12M 49.87M 2024-09
Genmab DKK 2.68B 1.98B 2024-12
Gilead Sciences USD 248M 10M 2024-12
GlaxoSmithKline 173M 17M 2024-12
GRIFOLS EUR 202.71M 94.07M 2024-06
Hikma Pharmaceutical 22M 9M 2024-06
J&J USD 137M 56M 2024-12
Lonza CHF 59M 6M 2024-06
Merck 89M 17M 2024-09
Merck USD 328M 2M 2024-12
Novartis USD 275M 11M 2024-12
Novartis USD 275M 11M 2024-12
Novo Nordisk 562M 40M 2024-09
Orion 1.1M 500K 2024-12
Pfizer USD 739M 45M 2024-12
Philips 104M 95.2M 2024-09
Recordati EUR 29.38M 13.85M 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 62M 17M 2024-12



Novartis Räntekostnad På Skuld - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.